Evidence used
- No CISA KEV confirmation is currently recorded.
- A structured source references public exploit or proof-of-concept material.
- EPSS is 2.24% for the current model date.
BlackTreeCVE IntelligenceUnknown · Unknown
High technical severity with public exploit material referenced by a structured source; prioritise exposed affected systems while verifying vendor guidance.
These OSV and GitHub advisory ranges apply only to the named package and ecosystem. A listed fixed version is not a universal product patch or proof that an update is installed.
| Ecosystem and package | Affected range | First fixed version | Evidence |
|---|---|---|---|
| composerdolibarr/dolibarr | <= 9.0.1 | 9.0.3 | GitHub advisory ↗github reviewed aggregator · 25 Aug 2023 |
High technical severity with public exploit material referenced by a structured source; prioritise exposed affected systems while verifying vendor guidance.
Fix not verifiedDolibarr ERP/CRM 9.0.1 provides a module named website that provides for creation of public websites with a WYSIWYG editor. It was identified that the editor also allowed inclusion of dynamic code, which can lead to code execution on the host machine. An attacker has to check a setting on the same page, which specifies the inclusion of dynamic content. Thus, a lower privileged user of the application can execute code under the context and permissions of the underlying web server.
Dolibarr ERP/CRM 9.0.1 provides a module named website that provides for creation of public websites with a WYSIWYG editor. It was identified that the editor also allowed inclusion of dynamic code, which can lead to code execution on the host machine. An attacker has to check a setting on the same page, which specifies the inclusion of dynamic content. Thus, a lower privileged user of the application can execute code under the context and permissions of the underlying web server.
Untrusted data can cross into a code-evaluation path and be interpreted as executable instructions.
An attacker operating through a network path may attempt exploitation with low privileges. If successful, the issue may execute code or commands in the affected security context.
Dolibarr ERP/CRM 9.0.1 provides a module named website that provides for creation of public websites with a WYSIWYG editor. It was identified that the editor also allowed inclusion of dynamic code, which can lead to code execution on the host machine. An attacker has to check a setting on the same page, which specifies the inclusion of dynamic content. Thus, a lower privileged user of the application can execute code under the context and permissions of the underlying web server.
Untrusted data can cross into a code-evaluation path and be interpreted as executable instructions.
An attacker operating through a network path may attempt exploitation with low privileges. If successful, the issue may execute code or commands in the affected security context.
CVSS severity, EPSS forecast probability, public exploit material and CISA-confirmed exploitation are separate signals.
No CISA KEV match was present at the last successful refresh. This means no confirmation from that source, not proof of no exploitation.
A structured CVE source labels at least one public reference as exploit material. BlackTree has not independently validated that it is safe, reliable or weaponised.
CWE-94: Improper Control of Generation of Code ('Code Injection'). The product constructs all or part of a code segment using externally-influenced input from an upstream component, but it does not neutralize or incorrectly neutralizes special elements that could modify the syntax or behavior of the intended code segment.
CVSS:3.0/AV:N/AC:L/PR:L/UI:R/S:U/C:H/I:H/A:HCommon Vulnerability Scoring System 3.0: the compact vector below is decoded into plain language.
Operational remediation based on structured source evidence.
Published 29 Jul 2019 · Last source change 4 Aug 2024, 22:48 UTC · CWE-94 · Improper Control of Generation of Code ('Code Injection')
Missing structured fields: affected product. Missing data is not evidence of low risk; review the primary advisory.